<DOC>
	<DOCNO>NCT02812875</DOCNO>
	<brief_summary>CA-170 rationally design orally available , small molecule directly target Programmed death-ligands 1 2 ( PD-L1/PD-L2 ) , V-domain Ig suppressor T cell activation ( VISTA ) immune checkpoint result activation T cell proliferation cytokine production . This multi-center , open-label , Phase 1 trial orally administer CA-170 adult patient advance solid tumor lymphomas progress non-responsive available therapy standard therapy exists .</brief_summary>
	<brief_title>A Study CA-170 ( Oral PD-L1 , PD-L2 VISTA Checkpoint Antagonist ) Patients With Advanced Tumors Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>1 . Males females ≥ 18 year age ; 2 . Life expectancy least 3 month ; 3 . ECOG PS ≤ 1 ; 4 . Acceptable bone marrow organ function screening ; 5 . Ability swallow retain oral medication ; 6 . Negative serum pregnancy test woman childbearing potential ; 7 . Measurable disease ; 8 . Tumor standard therapy , include approve antiPD1 antiPDL1 therapy , applicable , exist longer effective . 1 . Prior treatment anticancer therapy use investigational agent within past 28 day 5 halflives , whichever short ; 2 . Toxicity prior chemotherapy resolve Grade ≤ 1 ; 3 . Radiotherapy within last 21 day ; 4 . Primary brain tumor CNS metastasis ; 5 . Major minor surgery &lt; 28 &lt; 14 day start treatment , respectively ; 6 . Active autoimmune disease medical condition require use systemic immunosuppressive medication ; 7 . Active infection require systemic therapy ; 8 . Receipt vaccines infectious disease within 28 day ; 9 . HIV positive AIDSrelated illness ; 10 . Active/chronic HBV HCV infection ; 11 . Uncontrolled CHF ( NYHA Class 24 ) , angina , MI , CVA , coronary/peripheral artery bypass graft surgery , TIA , PE prior 3 month ; 12 . Cardiac dysrhythmias ; 13 . Gastrointestinal disease interfere receipt oral drug ; 14 . Concomitant malignancy ; 15 . Pregnant lactate female ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>